Merck Can't ACHIEVE Anything
                   
pharmiweb.co.uk     22-May-2008            

By Brian Orelli May 22, 2008 Comments (0) What do you get when you combine a trial design that failed to show improved patient outcomes, two cholesterol-lowering drugs, and an FDA not-approvable letter? Merck (NYSE: MRK) announced yesterday that it was cancelling its ACHIEVE (An Assessment of... [read full story]                    


View all news articles about*:
Aid AstraZeneca Banking Bill Care Cholesterol Diet Drugs Finance Financial Genzyme Health Insurance Investing Isis Mann Markets Medicines Patients Pharmaceuticals Remedies Schering Stock
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

Court in Denmark Upholds Two Lipitor Patents, Prevents Launch of Ranbaxy Generic Product before No..

euroinvestor.co.uk     4 hrs ago   2 related          

Pfizer Inc said today that the Eastern Division of the High Court in Copenhagen, Denmark has ruled in the company’s favor in challenges to two of its patents covering atorvastatin, the active ingredient in Lipitor. The...                    

comments

                   

Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for Byetta

pharmiweb.co.uk     27-Aug-2008   61 related          

SAN DIEGO and INDIANAPOLIS, August 26, 2008 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. and Eli Lilly and Company in a conference call today provided context and additional information regarding the August 18,...                    

comments

Pharma is warned to harness internet

pharmiweb.co.uk     57 mins ago          

Gemma O'Reilly 29-Aug-08 Healthcare PROs have been advised to reconsider their approach to patient communications following new research that shows the expanding reach of the internet. Ogilvy Healthworld questioned 1,800...                    

comments

Cubist Pharmaceuticals to Present at September Investor Conferences

euroinvestor.co.uk     2 hrs ago   4 related          

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Robert Perez, EVP and COO, will present on Thursday, September 4th at 2:40 P.M. EDT, at the Thomas Weisel Partners Healthcare Conference being held at the...                    

comments